Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Posted September 22, 2024.
Assessing Variation in First-Line Type 2 Diabetes Treatment across eGFR Levels and Providers
